What is Generate Biomedicines, Inc. 's restricted cash?

Generate Biomedicines, Inc. (GENB) reported restricted cash of $0 in Q1 2026.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Generate Biomedicines, Inc. GENB Restricted Cash

Restricted Cash at other companies

AppFolioAPPF

$250K0.0%

American Healthcare REITAHR

$37.5M-9.4%

Navitas Semiconductor CorporationNVTS

$2.36M+389%

ALN

Alnylam PharmaceuticalsALNY

$1.64M-36.8%

Vail ResortsMTN

$15.95M+15.7%

Taylor Morrison Home CorporationTMHC

$500K+73.6%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's restricted cash?: Generate Biomedicines, Inc. (GENB) reported restricted cash of $0 in Q1 2026.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.